Filing Details
- Accession Number:
- 0001645627-18-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-05 18:52:06
- Reporting Period:
- 2018-08-29
- Accepted Time:
- 2018-09-05 18:52:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 35,500 shares | Avg. Price: $0.04 | Total Value: $1,433.40 |
| Number of Shares After Transactions: | 25,823,598 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-29 | 2,000 | $0.05 | 25,790,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.05 | 25,791,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.05 | 25,792,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.05 | 25,793,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.05 | 25,794,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,795,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,796,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,797,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,798,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 500 | $0.04 | 25,798,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,799,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,800,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 2,000 | $0.04 | 25,802,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,803,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 2,000 | $0.04 | 25,805,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.03 | 25,806,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,807,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 3,000 | $0.03 | 25,810,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.03 | 25,811,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 2,000 | $0.04 | 25,813,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,814,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,815,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,816,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,817,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,818,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,819,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,820,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,821,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,822,598 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 1,000 | $0.04 | 25,823,598 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
